BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32816159)

  • 1. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.
    Zhao XF; Yang YS; Park YK
    Int J Clin Oncol; 2020 Dec; 25(12):2044-2054. PubMed ID: 32816159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
    Hu M; Ou-Yang W; Jing D; Chen R
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
    Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP
    World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
    Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancer.
    Niu Y; Li F; Tang B; Shi Y; Hao Y; Yu P
    Int J Clin Exp Pathol; 2014; 7(8):5144-53. PubMed ID: 25197388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer.
    Peng X; Kang Q; Wan R; Wang Z
    Cell Physiol Biochem; 2018; 49(4):1659-1676. PubMed ID: 30205370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.
    Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H
    Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
    Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer.
    He H; Chen W; Wang X; Wang C; Liu F; Shen Z; Xu J; Gu J; Sun Y
    Cancer Sci; 2012 Jul; 103(7):1296-303. PubMed ID: 22471696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
    Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
    World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of the ANKRD49 protein is associated with progression and poor prognosis of gastric cancer.
    Liu CG; Cui XL; Wei ZG; Guo JS
    Cancer Biomark; 2018; 22(4):649-656. PubMed ID: 29865034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.